Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.54
0.03 (1.99%)
At close: Aug 15, 2025, 12:30 PM

Pulmonx Statistics

Share Statistics

Pulmonx has 40.75M shares outstanding. The number of shares has increased by 2.82% in one year.

40.75M
2.82%
1.16%
90.49%
35.88M
68
0.01%

Short Selling Information

The latest short interest is 1.44M, so 3.62% of the outstanding shares have been sold short.

1.44M
3.62%
5.1%
3.85

Valuation Ratios

The PE ratio is -4.71 and the forward PE ratio is -1.18. Pulmonx's PEG ratio is 0.47.

-4.71
-1.18
3.17
0.6
3.09
-8.05
0.47
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pulmonx.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.

5.58
4.88
0.66
-1.11
-1.71
-16.45

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$287.93K
$-193.79K
291
0.51
1.29

Taxes

500K
-0.89%

Stock Price Statistics

The stock price has increased by -72.98% in the last 52 weeks. The beta is 0.43, so Pulmonx's price volatility has been higher than the market average.

0.43
-72.98%
2.78
5.34
27.97
538,925

Income Statement

In the last 12 months, Pulmonx had revenue of 83.79M and earned -56.39M in profits. Earnings per share was -1.44.

83.79M
62M
-57.7M
-56.39M
-50.79M
-52.39M
-1.44
Full Income Statement

Balance Sheet

The company has 70.91M in cash and 56.47M in debt, giving a net cash position of 14.43M.

70.91M
56.47M
14.43M
-467.56M
147.19M
97.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.54M and capital expenditures -1.45M, giving a free cash flow of -32.98M.

-31.54M
-1.45M
-32.98M
-0.84
Full Cash Flow Statement

Margins

Gross margin is 74%, with operating and profit margins of -68.87% and -67.3%.

74%
-68.87%
-66.71%
-67.3%
-60.62%
-68.87%
-39.37%

Dividends & Yields

LUNG does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for LUNG is $5, which is 224.7% higher than the current price. The consensus rating is "Buy".

$5
224.7%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.28
2